Feature Channels:

Kidney Disease

Add to Favorites Subscribe Share
mmc-logo.gif

Certain liver cells may help prevent organ rejection after transplant and other conditions, study finds

Mayo Clinic

Mesenchymal stromal cells from fat tissue and bone marrow are widely used in therapeutic trials for their anti-inflammatory qualities, but new Mayo Clinic research finds that liver cells may be of greater value. The study, published in Liver Transplantation, finds that liver mesenchymal stromal cells have immunoregulatory qualities that make them more effective than similar cells derived from adipose, or fat, tissue and bone marrow.

Channels: Immunology, Kidney Disease, Liver Disease, Transplantation,

Released:
20-Jan-2020 2:25 PM EST
Embargo will expire:
23-Jan-2020 5:00 PM EST
Released to reporters:
20-Jan-2020 9:00 AM EST

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 23-Jan-2020 5:00 PM EST

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Research Results
Embargo will expire:
23-Jan-2020 5:00 PM EST
Released to reporters:
17-Jan-2020 2:50 PM EST

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 23-Jan-2020 5:00 PM EST

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Research Results
Newswise: UTSW Researchers Uncover New Vulnerability in Kidney Cancer

UTSW Researchers Uncover New Vulnerability in Kidney Cancer

UT Southwestern Medical Center

Qing Zhang, Ph.D., and his colleagues identified a possible way to treat tumors while sparing nearby healthy tissue.

Channels: Cancer, Kidney Disease, All Journal News,

Released:
16-Jan-2020 4:55 PM EST
Research Results
Newswise: Hackensack University Medical Center First Hospital in New Jersey to Perform Kidney Transplant Using Cutting-Edge, Life-Saving Technology

Hackensack University Medical Center First Hospital in New Jersey to Perform Kidney Transplant Using Cutting-Edge, Life-Saving Technology

Hackensack Meridian Health

Hackensack Meridian Hackensack University Medical Center today announced that it became the first hospital in the New Jersey to perform a kidney transplant with a kidney preserved at its own Organ Preservation Center using the LifePort Kidney Transporter, an ex vivo hypothermic machine preservation technology. Hypothermic machine preservation is a cutting-edge, life-saving technology that increases a kidney’s viability and lifespan, improving patient outcomes.

Channels: Kidney Disease, Surgery, Transplantation,

Released:
16-Jan-2020 1:50 PM EST
Research Results
and-logo.jpg
  • Embargo expired:
    15-Jan-2020 1:00 PM EST
Released:
14-Jan-2020 11:55 AM EST
Feature

American Society of Nephrology Develops Kidney Care First Model Calculator for Nephrology Practices

American Society of Nephrology (ASN)

The American Society of Nephrology (ASN) has developed a Kidney Care First (KCF) Model Calculator, a tool that will help nephrologists anticipate how their practices might perform if they choose to participate in the new payment program.

Channels: Healthcare, In the Workplace, Kidney Disease,

Released:
14-Jan-2020 10:55 AM EST
Research Results
sum-logo.gif

'Ageotypes' provide window into how individuals age, Stanford study reports

Stanford University School of Medicine

What's your type? That question could gain new meaning, thanks to scientists who've categorized how humans age into different classes dubbed "ageotypes," reports a new study from the Stanford University School of Medicine.

Channels: Aging, Autoimmune Diseases, Cell Biology, Genetics, Immunology, Kidney Disease, Liver Disease, Nature (journal), All Journal News,

Released:
13-Jan-2020 12:50 PM EST
Policy
  • Embargo expired:
    9-Jan-2020 5:00 PM EST

Heart Disease Linked to a Higher Risk of Kidney Failure

American Society of Nephrology (ASN)

• In adults followed for a median of 17.5 years, cardiovascular diseases—including heart failure, atrial fibrillation, coronary heart disease, and stroke—were each linked with a higher risk of developing kidney failure. • Heart failure was associated with the highest risk: adults hospitalized with heart failure had an 11.4-times higher risk of developing kidney failure than individuals without cardiovascular disease.

Channels: Cardiovascular Health, Healthcare, Heart Disease, Kidney Disease, All Journal News,

Released:
3-Jan-2020 2:30 PM EST
Research Results

House Energy and Commerce Committee Holds Hearing on Immunosuppressive Drug Coverage, a Key Legislative Priority of American Society of Nephrology

American Society of Nephrology (ASN)

Washington, DC (January 8, 2020) — The House Energy and Commerce Committee is scheduled to hold a hearing on Wednesday, January 8, on the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2019, advancing a long-standing legislative priority of the American Society of Nephrology.

Channels: Government/Law, Healthcare, Kidney Disease, Pharmaceuticals,

Released:
8-Jan-2020 3:00 PM EST
Research Results


2.76403